100 healthy years - are kids prepared?

MerckMerck, a leading science and technology company, convened experts from diverse reputable organizations such as UN, UNICEF, UNAIDS, World Obesity Federation and McKinsey at the company's headquarters in Darmstadt, Germany, to debate relevant questions such as: What are the most urgent threats to our children's long-term health? What can be done both inside and outside the classroom? And how do schools, parents and communities share responsibility?

As global life expectancy continues to increase, World Health Organization statistics show that the children of today are likely to be the first to live 100 years. But living 100 healthy years - with vitality and mobility - and the challenge of equipping children to do so, was the subject of yesterday's second annual 'Global Consumer Health Debate'.

Uta Kemmerich-Keil, CEO and President of the Consumer Health business of Merck commented: "One thing is for certain: the earlier we start working with kids on how to look after themselves, the better the long-term impacts. If this debate helped strengthen the health education for my own kids here in Germany, as much as children from Brazil to India, then we are getting better at building a global future of healthy adults, able to enjoy a long life to the fullest."

The event released the findings of the Economist Intelligence Unit's (EIU) white paper: "Kids and Old Age". This worldwide study describes the current landscape: What according to parents, educators, policy makers, research institutions, and development actors can be done to better prepare kids for a long and healthy life? Key findings include:

  • Today's children will be less healthy than today’s adults over 65 when they reach that age.
  • Lifestyle-related problems are likely to contribute to chronic disease in later life and are already causing health problems among children.
  • Across the five countries surveyed, schools are targeting the main perceived problems, such as lack of exercise, but are ignoring mental health issues.
  • There is little evidence that such school education programmes are managing to stem rising rates of obesity and mental disorders.

By bringing many actors together, the debate 'joined the dots' between all those responsible for children’s health and well-being, and created consensus around collaborative thinking and common goals.

However this debate - and the diversity of actors and opinions - highlighted how our childhood lessons are drawn from far beyond our homes and schools, such as community efforts and policy-level support. The key message is that by working together on complementary efforts that our kids will be better equipped to become tomorrow's healthy adults and elderly.

The international panels included voices as diverse as government representatives of South Africa (Ministry of Basic Education), UN representatives of education, children's and health priorities (UNICEF, Every Woman for Every Child/UN, UNAIDS), Brazilian and Indian community-based organizations (Inmed Brazil, Smile Foundation) having huge impacts on the ground, business consultants to the health industry (McKinsey), and the World Obesity Federation.

The event marked an important milestone in Merck Consumer Health's journey to "Prepare society for a new era of humans living 100 healthy years". This business purpose is at the heart of Merck Consumer Health's WE100® movement, aimed at raising awareness of healthy living, for people of all ages. While the report and the debate helped to focus the global conversation, it seems to be even more crucial to create and take action. WE100 is Merck's commitment to do so.

About the Consumer Health business of Merck
Brands of the Consumer Health business, such as Neurobion®, Bion®, Nasivin®, Seven Seas®, Dolo-Neurobion®, and Femibion® are innovative leaders in key markets, backed by science and trusted by consumers worldwide. The Consumer Health business is with over 3,800 employees globally active in over 40 markets. The portfolio comprises of brands with annual total sales of about $ 1 billion. Consumer Health is a business of the Healthcare business sector within the Merck Group with global headquarters in Darmstadt, Germany.

About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Most Popular Now

Fasenra (benralizumab) receives US FDA approval fo…

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab)...

Alzheimer's disease might be a 'whole body' proble…

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scie...

Cancer cells destroyed with dinosaur extinction me…

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international col...

Novartis confirms leadership in multiple sclerosis…

Novartis today announced it will present 54 scientific abstracts from across its multiple sclerosis (MS) research portfolio at the 7th Joint European and Americas Committ...

Amgen and Novartis announce expanded collaboration…

Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Init...

Transplanted hematopoietic stem cells reverse dama…

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mous...

Novartis announces the planned acquisition of Adva…

Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender...

'Precision Medicine' may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the w...

New tissue-engineered blood vessel replacements on…

Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doe...

China's out of control 'silent killer' affects one…

More than one-third of adults in China have high blood pressure - often dubbed the "silent killer" for its lack of symptoms - but only about one in 20 have the condition ...

New US study reveals key reasons why millions of p…

Few of the more than 90 million Americans(1) with obesity are seeking and receiving long-term obesity care, according to new data from the Awareness, Care and Treatment I...

SMi Group announces the 9th Annual RNA Therapeutic…

21 - 22 February 2018, London, UK. As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]